Related Articles
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo
Vandetanib inhibits both VEGFR-2 and EGFR signalling at clinically relevant drug levels in preclinical models of human cancer
Poly(ADP-ribose) polymerase inhibitor olaparib hampers placental growth factor-driven activation of myelomonocytic cells
γ-secretase inhibitor up-regulates vascular endothelial growth factor receptor-2 and endothelial nitric oxide synthase
Vascular endothelial growth factor directly stimulates tumour cell proliferation in non-small cell lung cancer